Regulus Therapeutics
RGLS
#8806
Rank
C$0.16 B
Marketcap
$2.54
Share price
-8.16%
Change (1 day)
-31.24%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -C$63.72 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -C$41.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 -C$65.12 Million56.97%
2023 -C$41.49 Million6.51%
2022 -C$38.95 Million2.53%
2021 -C$37.99 Million93.59%
2020 -C$19.63 Million-15.41%
2019 -C$23.2 Million-64.46%
2018 -C$65.27 Million-33.26%
2017 -C$97.79 Million-13.98%
2016 -C$0.12 Billion44.77%
2015 -C$78.53 Million-1.63%
2014 -C$79.83 Million203.6%
2013 -C$26.3 Million8.65%
2012 -C$24.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$6.19 B-9,611.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$11.19 B-17,290.56%๐Ÿ‡ซ๐Ÿ‡ท France
C$2.68 B-4,225.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.70 B-22,682.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
-C$0.34 Billion 409.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.14 Billion 113.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.81 Billion 18,036.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion 154.66%๐Ÿ‡บ๐Ÿ‡ธ USA